On January 3, 2020, Brian B. Yoor, Executive Vice President, Finance and Chief Financial Officer, informed Abbott Laboratories that he will retire as an officer of the company, effective February 29, 2020. On January 7, 2020, Abbott's Board of Directors appointed Robert E. Funck, Jr., 58, as Executive Vice President, Finance and Chief Financial Officer, effective March 1, 2020. Mr. Funck has served as Abbott's Senior Vice President, Finance and Controller since 2018 and served as Vice President, Controller from 2013 to 2018, as Vice President, Chief Ethics and Compliance Officer from 2009 to 2013, as Vice President, Internal Audit from 2007 to 2009, and as Vice President and Treasurer from 2005 to 2007.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
104.7 USD | +0.07% | -1.10% | -4.84% |
05-09 | Drugmaker Abbott India posts Q4 profit rise on higher sales | RE |
05-08 | Abbott Laboratories Insider Sold Shares Worth $2,428,119, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.84% | 40.7B | |
+24.51% | 32.25B | |
+3.43% | 26.53B | |
+15.25% | 25.02B | |
-0.32% | 24.96B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Abbott Laboratories Announces Management Changes